Annual EBITDA
-$10.50 M
+$4.40 M+29.52%
December 31, 2022
Summary
- As of February 7, 2025, HSTO annual EBITDA is -$10.50 million, with the most recent change of +$4.40 million (+29.52%) on December 31, 2022.
- During the last 3 years, HSTO annual EBITDA has fallen by -$9.58 million (-1036.69%).
- HSTO annual EBITDA is now -1036.69% below its all-time high of -$924.00 thousand, reached on December 31, 2019.
Performance
HSTO EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$3.83 M
-$1.78 M-86.83%
September 30, 2023
Summary
- As of February 7, 2025, HSTO quarterly EBITDA is -$3.83 million, with the most recent change of -$1.78 million (-86.83%) on September 30, 2023.
- Over the past year, HSTO quarterly EBITDA has dropped by -$269.00 thousand (-7.55%).
- HSTO quarterly EBITDA is now -487.42% below its all-time high of -$652.00 thousand, reached on March 31, 2022.
Performance
HSTO Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$12.25 M
-$269.00 K-2.25%
September 30, 2023
Summary
- As of February 7, 2025, HSTO TTM EBITDA is -$12.25 million, with the most recent change of -$269.00 thousand (-2.25%) on September 30, 2023.
- Over the past year, HSTO TTM EBITDA has dropped by -$1.54 million (-14.44%).
- HSTO TTM EBITDA is now -620.78% below its all-time high of -$1.70 million, reached on June 30, 2019.
Performance
HSTO TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
HSTO EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +29.5% | -7.5% | -14.4% |
| 3 y3 years | -1036.7% | -15.3% | -15.3% |
| 5 y5 years | -1036.7% | -125.4% | -107.5% |
HSTO EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +29.5% | -487.4% | at low | -16.6% | +17.8% |
| 5 y | 5-year | -1036.7% | +43.7% | -487.4% | +63.6% | -107.5% | +45.1% |
| alltime | all time | -1036.7% | +43.7% | -487.4% | +63.6% | -620.8% | +45.1% |
Histogen EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2023 | - | -$3.83 M(+86.8%) | -$12.25 M(+2.2%) |
| Jun 2023 | - | -$2.05 M(-40.3%) | -$11.98 M(-9.9%) |
| Mar 2023 | - | -$3.44 M(+17.3%) | -$13.29 M(+26.5%) |
| Dec 2022 | -$10.50 M(-29.5%) | -$2.93 M(-17.7%) | -$10.50 M(-1.9%) |
| Sep 2022 | - | -$3.56 M(+6.0%) | -$10.70 M(-2.4%) |
| Jun 2022 | - | -$3.36 M(+415.3%) | -$10.97 M(-3.0%) |
| Mar 2022 | - | -$652.00 K(-79.2%) | -$11.30 M(-24.1%) |
| Dec 2021 | -$14.90 M | -$3.13 M(-18.3%) | -$14.90 M(-33.2%) |
| Sep 2021 | - | -$3.83 M(+3.6%) | -$22.30 M(+2.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2021 | - | -$3.69 M(-13.1%) | -$21.79 M(+3.4%) |
| Mar 2021 | - | -$4.25 M(-59.6%) | -$21.08 M(+13.0%) |
| Dec 2020 | -$18.66 M(+1918.9%) | -$10.52 M(+216.7%) | -$18.66 M(+75.6%) |
| Sep 2020 | - | -$3.32 M(+11.4%) | -$10.62 M(+17.9%) |
| Jun 2020 | - | -$2.98 M(+63.4%) | -$9.01 M(+16.6%) |
| Mar 2020 | - | -$1.83 M(-26.7%) | -$7.73 M(+30.9%) |
| Dec 2019 | -$924.00 K | -$2.49 M(+45.4%) | -$5.90 M(+73.0%) |
| Sep 2019 | - | -$1.71 M(+0.8%) | -$3.41 M(+100.8%) |
| Jun 2019 | - | -$1.70 M | -$1.70 M |
FAQ
- What is Histogen annual EBITDA?
- What is the all time high annual EBITDA for Histogen?
- What is Histogen annual EBITDA year-on-year change?
- What is Histogen quarterly EBITDA?
- What is the all time high quarterly EBITDA for Histogen?
- What is Histogen quarterly EBITDA year-on-year change?
- What is Histogen TTM EBITDA?
- What is the all time high TTM EBITDA for Histogen?
- What is Histogen TTM EBITDA year-on-year change?
What is Histogen annual EBITDA?
The current annual EBITDA of HSTO is -$10.50 M
What is the all time high annual EBITDA for Histogen?
Histogen all-time high annual EBITDA is -$924.00 K
What is Histogen annual EBITDA year-on-year change?
Over the past year, HSTO annual EBITDA has changed by +$4.40 M (+29.52%)
What is Histogen quarterly EBITDA?
The current quarterly EBITDA of HSTO is -$3.83 M
What is the all time high quarterly EBITDA for Histogen?
Histogen all-time high quarterly EBITDA is -$652.00 K
What is Histogen quarterly EBITDA year-on-year change?
Over the past year, HSTO quarterly EBITDA has changed by -$269.00 K (-7.55%)
What is Histogen TTM EBITDA?
The current TTM EBITDA of HSTO is -$12.25 M
What is the all time high TTM EBITDA for Histogen?
Histogen all-time high TTM EBITDA is -$1.70 M
What is Histogen TTM EBITDA year-on-year change?
Over the past year, HSTO TTM EBITDA has changed by -$1.54 M (-14.44%)